Literature DB >> 8267642

Inhibition of epidermal growth factor receptor tyrosine kinase activity by hypericin.

P de Witte1, P Agostinis, J Van Lint, W Merlevede, J R Vandenheede.   

Abstract

The naphthodianthrone hypericin produces a potent and irreversible inhibition of the epidermal growth factor (EGF) receptor tyrosine kinase activity. The inhibition was time and temperature dependent but did not depend on EGF activation. The IC50 values obtained were 0.37-8.7 microM with membranes incubated for 30 min at 30 degrees or 10 min at 0 degree, respectively. Kinetic analyses with poly(Glu,Ala,Tyr) 6:3:1 [poly(GAT)] as an exogenous substrate were in agreement with the irreversible nature of the inhibition. Irradiation for 30 min with fluorescent light caused a dramatic photosensitizing effect and resulted in an IC50 value of 44 nM. This effect was due to a type I mechanism, since the exclusion of oxygen did not alter the inhibition curve. The inhibition was inversely proportional to the amounts of membranes used, which probably reflects the non-specific sequestration of hypericin into the lipid bilayer. Ser/Thr protein kinases such as protein kinase A, casein kinase 1 and 2 and the enzyme 5'-nucleotidase, were not inhibited by hypericin not even at high concentrations (> 100 microM).

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8267642     DOI: 10.1016/0006-2952(93)90633-8

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  7 in total

Review 1.  Antiviral therapy for human immunodeficiency virus infections.

Authors:  E De Clercq
Journal:  Clin Microbiol Rev       Date:  1995-04       Impact factor: 26.132

2.  Evaluation of the in vitro inhibitory impact of hypericin on placental glutathione S-transferase pi.

Authors:  Ozlem Dalmizrak; Gulnihal Kulaksiz-Erkmen; Nazmi Ozer
Journal:  Protein J       Date:  2012-10       Impact factor: 2.371

3.  Hypericum in infection: Identification of anti-viral and anti-inflammatory constituents.

Authors:  Diane F Birt; Mark P Widrlechner; Kimberly Dp Hammer; Matthew L Hillwig; Jingqiang Wei; George A Kraus; Patricia A Murphy; Joeann McCoy; Eve S Wurtele; Jeffrey D Neighbors; David F Wiemer; Wendy J Maury; Jason P Price
Journal:  Pharm Biol       Date:  2009       Impact factor: 3.503

4.  Identification of kinase inhibitors that target transcription initiation by RNA polymerase II.

Authors:  José M Morachis; Ruo Huang; Beverly M Emerson
Journal:  Oncotarget       Date:  2011 Jan-Feb

Review 5.  Targeting the hallmarks of cancer with therapy-induced endoplasmic reticulum (ER) stress.

Authors:  Abhishek D Garg; Hannelore Maes; Alexander R van Vliet; Patrizia Agostinis
Journal:  Mol Cell Oncol       Date:  2014-12-01

Review 6.  Biophysical Characterization and Anticancer Activities of Photosensitive Phytoanthraquinones Represented by Hypericin and Its Model Compounds.

Authors:  Valéria Verebová; Jiří Beneš; Jana Staničová
Journal:  Molecules       Date:  2020-12-01       Impact factor: 4.411

7.  The basal transcription machinery as a target for cancer therapy.

Authors:  Claudia Villicaña; Grisel Cruz; Mario Zurita
Journal:  Cancer Cell Int       Date:  2014-02-28       Impact factor: 5.722

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.